"Malignant pleural effusion" trang 1 - tải miễn phí từ tailieunhanh
Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: A retrospective cohort study

Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: A retrospective cohort study
8    48    1
Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer

Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer
11    35    2
Combined ultrasound-guided cuttingneedle biopsy and standard pleural biopsy for diagnosis of malignant pleural effusions

Combined ultrasound-guided cuttingneedle biopsy and standard pleural biopsy for diagnosis of malignant pleural effusions
9    34    1
Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis

Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis
8    68    1
Study characteristics of malignant pleural effusion in the respiratory center, 103 military hospital in 5 years (2014-2019)

Study characteristics of malignant pleural effusion in the respiratory center, 103 military hospital in 5 years (2014-2019)
6    91    0
Important prognostic factors for survival in patients with malignant pleural effusion

Important prognostic factors for survival in patients with malignant pleural effusion
7    46    1
Diagnostic role of interleukin 33 in the differentiation of pleural effusions especially tuberculous and malignant effusions

Diagnostic role of interleukin 33 in the differentiation of pleural effusions especially tuberculous and malignant effusions
8    48    1
Diagnostic value of medical thoracoscopy in malignant pleural effusion

Diagnostic value of medical thoracoscopy in malignant pleural effusion
5    34    1
Indwelling pleural catheters for malignancy-associated pleural effusion: Report on a single centre’s ten years of experience

Indwelling pleural catheters for malignancy-associated pleural effusion: Report on a single centre’s ten years of experience
10    31    1
Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer

Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer
8    40    1
Pleural fluid osteopontin, vascular endothelial growth factor, and urokinasetype plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: A prospective cohort study

Pleural fluid osteopontin, vascular endothelial growth factor, and urokinasetype plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: A prospective cohort study
8    61    1
Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples

Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples
10    90    0
An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion

An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion
8    92    0
Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients

Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients
8    75    1
Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer

Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer
12    27    1
Safety of indwelling pleural catheter use in patients undergoing chemotherapy: A fiveyear retrospective evaluation

Safety of indwelling pleural catheter use in patients undergoing chemotherapy: A fiveyear retrospective evaluation
6    39    1
Metastatic papillary thyroid carcinoma in pleural effusion: A case report and review of the literature

Metastatic papillary thyroid carcinoma in pleural effusion: A case report and review of the literature
8    8    1
Evaluation of efficacy and safety for Brucea javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion

Evaluation of efficacy and safety for Brucea javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion
13    34    1
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: A cohort study

Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: A cohort study
9    25    1
Báo cáo khoa học:

Báo cáo khoa học: "Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system"
4    57    0